Hematopoietic cell transplantation in non-Hodgkin's lymphoma.
To explore the role and outcomes using hematopoietic cell transplantation (HCT) as a treatment option with aggressive, follicular, mantle, T-cell, and HIV related non-Hodgkin's lymphoma (NHL). Research and review articles and textbooks. High-dose chemotherapy and/or radiation therapy followed by HCT has been used to overcome resistance to standard-dose therapy and has been explored over the past 40 years and has shown long-term survival of approximately 10% to 50% in patients with relapsed or refractory lymphoma. Nursing plays a significant role in the assessment and management of patients throughout the course of HCT.